Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03).
Hospital medicine: It's gotten bigger, but can we make it better?
Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment.
ß1 integrin is a crucial regulator of pancreatic ß-cell expansion.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03).
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03). J Clin Oncol. 2022 01 20; 40(3):282-293.
View in:
PubMed
subject areas
Antineoplastic Agents, Hormonal
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Chemotherapy, Adjuvant
Disease Progression
Disease-Free Survival
Female
Humans
Mastectomy
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Piperazines
Prospective Studies
Protein Kinase Inhibitors
Pyridines
Time Factors
authors with profiles
Olwen Hahn